ide effects not listed above may also occur in some people.
After using VFEND
Storage
VFEND Tablets
Keep your tablets in the pack until it is time to use them.
If you take the tablets out of the blister pack they may not keep well.
Keep your tablets in a cool dry place where the temperature stays below 30°C.
VFEND Oral Suspension
Your pharmacist will store VFEND Oral Suspension in a powder form at 2°C to 8°C in the refrigerator before reconstitution.
Store prepared suspension in a cool dry place where the temperature stays below 30°C.
Discard suspension 14 days after preparation.
Do not store VFEND or any other medicine in the bathroom or near a sink. Do not leave it on a window sill or in the car.
Heat and dampness can destroy some medicines.
Keep your medicine where children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.
VFEND IV
VFEND IV will be stored in the pharmacy or on the hospital ward and is kept below 30°C.
Disposal
If your doctor tells you to stop taking this medicine or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.
Product description
What it looks like
VFEND Tablets
VFEND Tablets come in two strengths, 50 mg and 200 mg.
VFEND 50 mg Tablets are white, round tablets marked VOR50 on one side and Pfizer on the other.
VFEND 200 mg Tablets are white, capsule shaped tablets marked VOR200 on one side and Pfizer on the other.
VFEND Oral Suspension
Once reconstituted, VFEND Oral Suspension is a white to off-white orange flavoured suspension. Each bottle contains 70 mL of suspension.
VFEND IV
VFEND IV comes as a white powder in a clear, colourless, glass vial which contains 200 mg of voriconazole.
Ingredients
Active Ingredients
VFEND 50 mg Tablets contain 50 mg of voriconazole as the active ingredient.
VFEND 200 mg Tablets contain 200 mg of voriconazole as the active ingredient.
VFEND Oral Suspension contains 40 mg/mL of voriconazole as the active ingredient.
VFEND IV contains 200 mg of voriconazole as the active ingredient in each 30 mL vial.
Inactive Ingredients
The 50 mg and 200 mg tablets contain the following other ingredients:
lactose
maize starch (pregelatinised)
croscarmellose sodium
povidone
magnesium stearate
hypromellose
titanium dioxide
glycerol triacetate
VFEND Oral Suspension contains the following other ingredients:
sucrose
colloidal anhydrous silica
titanium dioxide
sodium citrate
xanthan gum
sodium benzoate
anhydrous citric acid
natural orange flavour
VFEND IV contains the following other ingredients:
Water for Injections
Sulfobutyl betadex sodium (SBECD).
Supplier
VFEND is supplied in Australia by:
Pfizer Australia Pty Ltd
ABN 50 008 422 348
38-42 Wharf Road
West Ryde NSW 2114
Toll Free Number: 1800 675 229
Australian Registration Numbers
VFEND 50 mg blister pack AUST R 82507
VFEND 200 mg blister pack AUST R 82505
VFEND Powder for Oral Suspension AUST R 99016
VFEND IV Powder for Injection AUST R 82503
Date of preparation
This leaflet was prepared in May 2011.
Pfizer Australia Pty Ltd
® Registered trademark of Pfizer Inc
|
